Roche Holding Ltd. (VTX:ROG)‘s stock had its “buy” rating reissued by stock analysts at J P Morgan Chase & Co in a report released on Friday.

Several other research firms have also recently commented on ROG. Sanford C. Bernstein set a CHF 284 price objective on shares of Roche Holding and gave the company a “buy” rating in a research report on Tuesday, July 18th. Jefferies Group LLC set a CHF 305 price objective on shares of Roche Holding and gave the company a “buy” rating in a research report on Saturday, May 20th. Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on shares of Roche Holding and gave the company a “buy” rating in a research report on Friday, May 26th. BNP Paribas set a CHF 250 price objective on shares of Roche Holding and gave the company a “neutral” rating in a research report on Tuesday, June 20th. Finally, Deutsche Bank AG set a CHF 260 price objective on shares of Roche Holding and gave the company a “neutral” rating in a research report on Friday, July 7th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of CHF 271.08.

Roche Holding (VTX:ROG) traded down 0.33% during trading on Friday, hitting CHK 242.10. 1,065,002 shares of the stock were exchanged. The stock has a 50 day moving average price of CHK 246.83 and a 200-day moving average price of CHK 251.11. Roche Holding has a 12-month low of CHK 218.30 and a 12-month high of CHK 273.00. The firm has a market capitalization of CHK 206.26 billion and a PE ratio of 20.95.

TRADEMARK VIOLATION WARNING: “Roche Holding Ltd. (ROG) Earns “Buy” Rating from J P Morgan Chase & Co” was reported by American Banking News and is the property of of American Banking News. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/07/28/roche-holding-ltd-rog-earns-buy-rating-from-j-p-morgan-chase-co.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.